<DOC>
	<DOCNO>NCT00609128</DOCNO>
	<brief_summary>The purpose research determine inflammatory substance involve cause allergic symptom eye . Allergic conjunctivitis common problem symptom temporary redness , itching , tear , swell eye . Substances release cell affect tissue cause allergic reaction eye elsewhere body .</brief_summary>
	<brief_title>Allergic Eye Disease Tear Mediators</brief_title>
	<detailed_description>Ocular allergy extremely common , affect 80 million people USA . Our research question : Are difference inflammatory mediator cell surface activation marker patient undergo seasonal allergic conjunctivitis compare sight threaten disease Atopic Keratoconjunctivitis ( AKC ) use anti-allergy eye drop , PATANOLÂ® ( olopatadine hydrochloride ) affect parameter ? Experimental Design : Ocular surface cell ( impression cytology ) tear ( via capillary tube ) collect allergic , non-allergic , AKC subject undergoing reaction induce either seasonal allergen topical allergen provocation ( specificity dose determine via skin test ) . Ocular surface cell evaluate surface activation marker . Tears evaluate mediator content . Tears also incubate peripheral blood eosinophil lymphocytes see effect adhesion conjunctival epithelial cell .</detailed_description>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>Skin test positive Able put drop eye Able tear collect</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>tear</keyword>
	<keyword>conjunctival epithelial cell</keyword>
	<keyword>olopatadine</keyword>
	<keyword>impression cytology</keyword>
</DOC>